Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Parkinson's Disease

  Free Subscription

Articles published in Brain Res

Retrieve available abstracts of 43 articles:
HTML format

Single Articles

    December 2023
  1. FLORES AJ, Bartlett MJ, Seaton BT, Samtani G, et al
    Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion.
    Brain Res. 2023;1821:148613.
    PubMed     Abstract available

    November 2023
  2. SMIT RD, Ghosh B, Campion TJ 3rd, Stingel R, et al
    STAT3 protects dopaminergic neurons against degeneration in animal model of Parkinson's disease.
    Brain Res. 2023;1824:148691.
    PubMed     Abstract available

  3. LIU X, Liu X, Liu Y, Yang B, et al
    Utility of serum neurofilament light chain and glial fibrillary acidic protein as diagnostic biomarkers of freezing of gait in Parkinson's disease.
    Brain Res. 2023;1822:148660.
    PubMed     Abstract available

  4. ZHANG L, Guo Y, Liu J, Li L, et al
    Transcranial direct current stimulation of the prefrontal cortex improves depression-like behaviors in rats with Parkinson's disease.
    Brain Res. 2023 Nov 1:148649. doi: 10.1016/j.brainres.2023.148649.
    PubMed     Abstract available

    October 2023
  5. ISMAEL S, Colvin RA, Lee D
    Activation of cyclic AMP signaling pathway in dopaminergic neurons rescues locomotion defects in a Drosophila larval model of Parkinson's disease.
    Brain Res. 2023 Oct 20:148641. doi: 10.1016/j.brainres.2023.148641.
    PubMed     Abstract available

    September 2023
  6. YIN N, Wang H, Wang Z, Feng K, et al
    A study of brain networks associated with Freezing of gait in Parkinson's disease using transfer entropy analysis.
    Brain Res. 2023 Sep 30:148610. doi: 10.1016/j.brainres.2023.148610.
    PubMed     Abstract available

  7. CABRAL LM, Oliveira LM, Miranda NC, Kawamoto EM, et al
    TNFR1-mediated neuroinflammation is necessary for respiratory deficits observed in 6-hydroxydopamine mouse model of Parkinsons Disease.
    Brain Res. 2023 Sep 25:148586. doi: 10.1016/j.brainres.2023.148586.
    PubMed     Abstract available

  8. SONG J, Zhao Y, Shan X, Luo Y, et al
    Active ingredients of Chinese medicine with immunomodulatory properties: NF-kappaB pathway and Parkinson's disease.
    Brain Res. 2023 Sep 23:148603. doi: 10.1016/j.brainres.2023.148603.
    PubMed     Abstract available

    August 2023
  9. UNAL I, Cansiz D, Beler M, Sezer Z, et al
    Sodium-dependent Glucose Co-Transporter-2 Inhibitor Empagliflozin Exerts Neuroprotective Effects in Rotenone-Induced Parkinson's Disease Model in Zebrafish; Mechanism Involving Ketogenesis and Autophagy.
    Brain Res. 2023 Aug 15:148536. doi: 10.1016/j.brainres.2023.148536.
    PubMed     Abstract available

    June 2023
  10. KHOT M, Sood A, Pushpa Tryphena K, Pinjala P, et al
    Dimethyl fumarate ameliorates Parkinsonian pathology by modulating autophagy and apoptosis via Nrf2-TIGAR-LAMP2/Cathepsin D axis.
    Brain Res. 2023 Jun 12:148462. doi: 10.1016/j.brainres.2023.148462.
    PubMed     Abstract available

  11. RAI P, Ratnaparkhi A, Kumar Roy J
    Rab11 rescues muscle degeneration and synaptic morphology in the park(13/+) Parkinson model of Drosophila melanogaster.
    Brain Res. 2023 Jun 9:148442. doi: 10.1016/j.brainres.2023.148442.
    PubMed     Abstract available

  12. OLIVEIRA LM, Severs L, Moreira TS, Ramirez JM, et al
    Ampakine CX614 increases respiratory rate in a mouse model of Parkinson's disease.
    Brain Res. 2023;1815:148448.
    PubMed     Abstract available

  13. ZHOU W, He J, Zhang C, Pan Y, et al
    Fiber-specific white matter alterations in Parkinson's disease patients with freezing of gait.
    Brain Res. 2023 Jun 2:148440. doi: 10.1016/j.brainres.2023.148440.
    PubMed     Abstract available

    May 2023
  14. HENRIQUE BINDA K, Landau AM, Chacur M, Brooks DJ, et al
    Treadmill exercise modulates nigral and hippocampal cannabinoid receptor type 1 in the 6-OHDA model of Parkinson's disease.
    Brain Res. 2023 May 31:148436. doi: 10.1016/j.brainres.2023.148436.
    PubMed     Abstract available

  15. ROUZITALAB A, Boulay CB, Sachs AJ
    Volitional Control of Beta Activities in Parkinson's Disease Patients.
    Brain Res. 2023 May 6:148394. doi: 10.1016/j.brainres.2023.148394.
    PubMed     Abstract available

    April 2023
  16. CONTI MAZZA MM, Centner A, Werner DF, Bishop C, et al
    Striatal serotonin transporter gain-of-function in L-DOPA-treated, hemi-parkinsonian rats.
    Brain Res. 2023 Apr 29:148381. doi: 10.1016/j.brainres.2023.148381.
    PubMed     Abstract available

    March 2023
  17. BOSCH TJ, Espinoza AI, Singh A
    Cerebellar oscillatory dysfunction during lower-limb movement in Parkinson's disease with freezing of gait.
    Brain Res. 2023;1808:148334.
    PubMed     Abstract available

  18. NING B, Wang Z, Wu Q, Deng Q, et al
    Acupuncture inhibits autophagy and repairs synapses by activating the mTOR pathway in Parkinson's disease depression model rats.
    Brain Res. 2023 Mar 11:148320. doi: 10.1016/j.brainres.2023.148320.
    PubMed     Abstract available

    February 2023
  19. MAO S, Teng X, Li Z, Zu J, et al
    Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson's Disease.
    Brain Res. 2023 Feb 6:148271. doi: 10.1016/j.brainres.2023.148271.
    PubMed     Abstract available

    November 2022
  20. WANG RF, Li YP, Zhang HY, Xu SS, et al
    Sleep benefit in patients with Parkinson's disease is associated with the dopamine transporter expression in putamen.
    Brain Res. 2022 Nov 29:148173. doi: 10.1016/j.brainres.2022.148173.
    PubMed     Abstract available

  21. LIN HC, Wu YH, Huang CW, Ker MD, et al
    Verification of the beta oscillations in the subthalamic nucleus of the MPTP-induced parkinsonian minipig model.
    Brain Res. 2022 Nov 12:148165. doi: 10.1016/j.brainres.2022.148165.
    PubMed     Abstract available

    October 2022
  22. XIE J, Li T, He T, Xu R, et al
    Deep brain stimulation on the external segment of the globus pallidus improves the electrical activity of internal segment of globus pallidus in a rat model of Parkinson's disease.
    Brain Res. 2022 Oct 3:148115. doi: 10.1016/j.brainres.2022.148115.
    PubMed     Abstract available

    June 2022
  23. NI W, Zhou J, Ling Y, Lu X, et al
    Neural stem cell secretome exerts a protective effect on damaged neuron mitochondria in Parkinson's disease model.
    Brain Res. 2022;1790:147978.
    PubMed     Abstract available

    May 2022
  24. NAZAROVA L, Liu H, Xie H, Wang L, et al
    Targeting gut-brain axis through Scalp-Abdominal electroacupuncture in Parkinson's disease.
    Brain Res. 2022 May 31:147956. doi: 10.1016/j.brainres.2022.147956.
    PubMed     Abstract available

  25. ISHOLA IO, Awogbindin IO, Olubodun-Obadun TG, Oluwafemi OA, et al
    Morin ameliorates rotenone-induced Parkinson disease in mice through antioxidation and anti-neuroinflammation: gut-brain axis involvement.
    Brain Res. 2022 May 30:147958. doi: 10.1016/j.brainres.2022.147958.
    PubMed     Abstract available

    March 2022
  26. LIU SH, Wang YL, Jiang SM, Wan XJ, et al
    Identifying the hub gene and immune infiltration of Parkinson's disease using bioinformatical methods.
    Brain Res. 2022 Mar 9:147879. doi: 10.1016/j.brainres.2022.147879.
    PubMed     Abstract available

  27. COGO S, Ho FY, Tosoni E, Tomkins JE, et al
    The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation.
    Brain Res. 2022;1778:147781.
    PubMed     Abstract available

    February 2022
  28. SUN X, Zhang C, Tao H, Yao S, et al
    LINC00943 acts as miR-338-3p sponge to promote MPP(+)-induced SK-N-SH cell injury by directly targeting SP1 in Parkinson's disease.
    Brain Res. 2022 Feb 3:147814. doi: 10.1016/j.brainres.2022.147814.
    PubMed     Abstract available

    January 2022
  29. FRANCELLE L, Mazzulli JR
    Neuroinflammation in Gaucher disease, neuronal ceroid lipofuscinosis, and commonalities with Parkinson's disease.
    Brain Res. 2022;1780:147798.
    PubMed     Abstract available

    November 2021
  30. ARAUJO-SILVA F, Santinelli FB, Felipe I Imaizumi L, Silveira APB, et al
    Temporal dynamics of cortical activity and postural control in response to the first levodopa dose of the day in people with Parkinson's disease.
    Brain Res. 2021 Nov 14:147727. doi: 10.1016/j.brainres.2021.147727.
    PubMed     Abstract available

    September 2021
  31. MEMOU A, Dimitrakopoulos L, Kedariti M, Kentros M, et al
    Defining (and blocking) neuronal death in Parkinson's disease: Does it matter what we call it?
    Brain Res. 2021 Sep 4:147639. doi: 10.1016/j.brainres.2021.147639.
    PubMed     Abstract available

    August 2021
  32. NIELSEN SD, Pearson NM, Seidler K
    The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on alpha-synuclein transport.
    Brain Res. 2021 Aug 6:147609. doi: 10.1016/j.brainres.2021.147609.
    PubMed     Abstract available

    May 2021
  33. ERICSSON M, von Saucken V, Newman AJ, Doehr L, et al
    Crowded organelles, lipid accumulation, and abnormal membrane tubulation in cellular models of enhanced alpha-synuclein membrane interaction.
    Brain Res. 2021;1758:147349.
    PubMed     Abstract available

    April 2021
  34. GAN C, Ma K, Wang L, Si Q, et al
    Dynamic functional connectivity changes in Parkinson's disease patients with REM sleep behavior disorder.
    Brain Res. 2021 Apr 11:147477. doi: 10.1016/j.brainres.2021.147477.
    PubMed     Abstract available

    March 2021
    Is there a special relationship between complex I activity and nigral neuronal loss in Parkinson's disease? A critical reappraisal.
    Brain Res. 2021 Mar 18:147434. doi: 10.1016/j.brainres.2021.147434.
    PubMed     Abstract available

  36. GUILLAUMIN A, Serra GP, Georges F, Wallen-Mackenzie A, et al
    Experimental investigation into the role of the subthalamic nucleus (STN) in motor control using optogenetics in mice.
    Brain Res. 2021;1755:147226.
    PubMed     Abstract available

  37. FERNANDEZ-ESPEJO E, Rodriguez de Fonseca F, Suarez J, Martin de Pablos A, et al
    Cerebrospinal fluid lactoperoxidase level is enhanced in idiopathic Parkinson's disease, and correlates with levodopa equivalent daily dose.
    Brain Res. 2021 Mar 4:147411. doi: 10.1016/j.brainres.2021.147411.
    PubMed     Abstract available

    January 2021
    Harnessing The Immune System For The Treatment Of Parkinson's Disease.
    Brain Res. 2021 Jan 29:147308. doi: 10.1016/j.brainres.2021.147308.
    PubMed     Abstract available

  39. LIU J, Hu H, Wu B
    RIPK1 inhibitor ameliorates the MPP(+)/MPTP-induced Parkinson's disease through the ASK1/JNK signalling pathway.
    Brain Res. 2021 Jan 29:147310. doi: 10.1016/j.brainres.2021.147310.
    PubMed     Abstract available

  40. WANG Y, Yao L, Gao S, Zhang G, et al
    Inhibition of striatal dopamine D5 receptor attenuates levodopa-induced dyskinesia in a rat model of Parkinson's disease.
    Brain Res. 2021 Jan 7:147266. doi: 10.1016/j.brainres.2020.147266.
    PubMed     Abstract available

  41. CRIAUD M, Kim JH, Zurowski M, Lobaugh N, et al
    Anxiety in Parkinson's Disease: Abnormal resting activity and connectivity.
    Brain Res. 2021 Jan 4:147235. doi: 10.1016/j.brainres.2020.147235.
    PubMed     Abstract available

  42. ZHOU S, Zhang D, Guo J, Chen Z, et al
    Deficiency of NEAT1 prevented MPP(+)-induced inflammatory response, oxidative stress and apoptosis in dopaminergic SK-N-SH neuroblastoma cells via miR-1277-5p/ARHGAP26 axis.
    Brain Res. 2021;1750:147156.
    PubMed     Abstract available

    November 2020
  43. FERRAZ CRUZ C, Maria Forti Barela A, Dona F, Gracioli Genoves G, et al
    Parkinson's disease delays predictable visual cue processing without affecting complex and unpredictable visual cue processing in postural control.
    Brain Res. 2020 Nov 25:147209. doi: 10.1016/j.brainres.2020.147209.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.